RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
4.025 |
Evidence |
|
PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
4.025 |
Evidence |
|
ICAM2 |
ICAM2: Intercellular adhesion molecule 2 precursor |
BAIAP2 |
BAIAP2: Brain-specific angiogenesis inhibitor 1-associated protein 2 |
4.025 |
Evidence |
|
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
SIGLEC12 |
SIGLEC12, SIGLECL1, UNQ9215/PRO34042, SLG: Sialic acid-binding Ig-like lectin 12 |
4.025 |
Evidence |
|
F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
RGS18 |
RGS18, RGS13: Regulator of G-protein signaling 18 |
4.025 |
Evidence |
|
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
4.025 |
Evidence |
|
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
ADAM33 |
ADAM33, UNQ873/PRO1891: ADAM 33 precursor |
4.025 |
Evidence |
|
TNFSF12 |
TNFSF13, APRIL, UNQ383/PRO715, TALL2, ZTNF2: Tumor necrosis factor ligand superf |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
4.025 |
Evidence |
|
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
RGS18 |
RGS18, RGS13: Regulator of G-protein signaling 18 |
4.025 |
Evidence |
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
MYO3A |
MYO3A: Myosin IIIA |
4.02 |
Evidence |
|
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
4.02 |
Evidence |
|
WASPIP |
IPI00552369 |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
4.02 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
MYO3A |
MYO3A: Myosin IIIA |
4.02 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
TSHR |
IPI00386365 |
4.02 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
GRIN1 |
GRIN1, NMDAR1: Glutamate [NMDA] receptor subunit zeta-1 precursor |
4.02 |
Evidence |
|
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
4.02 |
Evidence |
|
SORBS3 |
SORBS3, SCAM1: Vinexin |
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
4.02 |
Evidence |
|
ELK1 |
ELK1: ETS domain-containing protein Elk-1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
4.02 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
4.02 |
Evidence |
|
CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
ATAD2 |
ATAD2, L16, PRO2000: ATPase family AAA domain-containing protein 2 |
4.02 |
Evidence |
|
WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
GRIA1 |
GRIA1, GLUH1, GLUR1: Glutamate receptor 1 precursor |
4.02 |
Evidence |
|
HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
4.017 |
Evidence |
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
IL2RG |
IL2RG: Cytokine receptor common gamma chain precursor |
4.017 |
Evidence |
|
FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
LILRA3 |
LILRA3, ILT6, LIR4: Leukocyte immunoglobulin-like receptor subfamily A member 3 |
4.017 |
Evidence |
|
PPP2CB |
PPP2CB: Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform |
GOPC |
GOPC, CAL, FIG: Golgi-associated PDZ and coiled-coil motif-containing protein |
4.017 |
Evidence |
|